2015

1. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: A randomized controlled trial

   Clinical Infectious Diseases, Vol. 60, Núm. 3, pp. 405-414